217 related articles for article (PubMed ID: 29665624)
1. Risk of gastrointestinal bleeding and benefit from colorectal cancer reduction from long-term use of low-dose aspirin: A retrospective study of 612 509 patients.
Tsoi KK; Chan FC; Hirai HW; Sung JJ
J Gastroenterol Hepatol; 2018 Oct; 33(10):1728-1736. PubMed ID: 29665624
[TBL] [Abstract][Full Text] [Related]
2. Safety and effectiveness of low-dose aspirin for the prevention of gastrointestinal cancer in adults without atherosclerotic cardiovascular disease: a population-based cohort study.
Shami JJP; Zhao J; Pathadka S; Wan EYF; Blais JE; Vora P; Soriano-Gabarró M; Cheung KS; Leung WK; Wong ICK; Chan EW
BMJ Open; 2022 Feb; 12(2):e050510. PubMed ID: 35121597
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Upper and Lower Gastrointestinal Bleeding in New Users of Low-Dose Aspirin.
Cea Soriano L; Lanas A; Soriano-Gabarró M; García Rodríguez LA
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):887-895.e6. PubMed ID: 29908361
[TBL] [Abstract][Full Text] [Related]
4. Incidences, temporal trends and risks of hospitalisation for gastrointestinal bleeding in new or chronic low-dose aspirin users after treatment for
Guo CG; Cheung KS; Zhang F; Chan EW; Chen L; Wong IC; Leung WK
Gut; 2020 Mar; 69(3):445-452. PubMed ID: 31101690
[TBL] [Abstract][Full Text] [Related]
5. Risk of lower gastrointestinal bleeding and colorectal neoplasms following initiation of low-dose aspirin: a Danish population-based cohort study.
Troelsen FS; Farkas DK; Erichsen R; Sørensen HT
BMJ Open Gastroenterol; 2020 Jul; 7(1):. PubMed ID: 32719046
[TBL] [Abstract][Full Text] [Related]
6. Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study.
Chan EW; Lau WC; Leung WK; Mok MT; He Y; Tong TS; Wong IC
Gastroenterology; 2015 Sep; 149(3):586-95.e3. PubMed ID: 25960019
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Colorectal Neoplasms and Mortality in New Users of Low-Dose Aspirin With Lower Gastrointestinal Bleeding.
Troelsen FS; Farkas DK; Ording AG; Erichsen R; Jick S; Sørensen HT
Am J Ther; 2021 Jan-Feb 01; 28(1):e19-e29. PubMed ID: 31356342
[TBL] [Abstract][Full Text] [Related]
8. Risks of Bleeding Recurrence and Cardiovascular Events With Continued Aspirin Use After Lower Gastrointestinal Hemorrhage.
Chan FK; Leung Ki EL; Wong GL; Ching JY; Tse YK; Au KW; Wu JC; Ng SC
Gastroenterology; 2016 Aug; 151(2):271-7. PubMed ID: 27130815
[TBL] [Abstract][Full Text] [Related]
9. Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: A Decision Analysis for the U.S. Preventive Services Task Force.
Dehmer SP; Maciosek MV; Flottemesch TJ; LaFrance AB; Whitlock EP
Ann Intern Med; 2016 Jun; 164(12):777-86. PubMed ID: 27064573
[TBL] [Abstract][Full Text] [Related]
10. New use of low-dose aspirin and risk of colorectal cancer by stage at diagnosis: a nested case-control study in UK general practice.
García Rodríguez LA; Soriano-Gabarró M; Bromley S; Lanas A; Cea Soriano L
BMC Cancer; 2017 Sep; 17(1):637. PubMed ID: 28882113
[TBL] [Abstract][Full Text] [Related]
11. Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin.
Sørensen HT; Mellemkjaer L; Blot WJ; Nielsen GL; Steffensen FH; McLaughlin JK; Olsen JH
Am J Gastroenterol; 2000 Sep; 95(9):2218-24. PubMed ID: 11007221
[TBL] [Abstract][Full Text] [Related]
12. Low-dose aspirin can reduce colorectal cancer mortality after surgery: A 10-year follow-up of 13 528 colorectal cancer patients.
Sung JJY; Ho JMW; Chan FCH; Tsoi KKF
J Gastroenterol Hepatol; 2019 Jun; 34(6):1027-1034. PubMed ID: 30515899
[TBL] [Abstract][Full Text] [Related]
13. The association between low-dose aspirin use and the incidence of colorectal cancer: a nationwide cohort study.
Huang WK; Chiou MJ; Yu KH; Lin YC; Yang TS; Chen JS; Kuo CF; See LC
Aliment Pharmacol Ther; 2013 Aug; 38(4):432-9. PubMed ID: 23799975
[TBL] [Abstract][Full Text] [Related]
14. Incidence of colorectal cancer in new users and non-users of low-dose aspirin without existing cardiovascular disease: A cohort study using The Health Improvement Network.
Cea Soriano L; Soriano-Gabarró M; García Rodríguez LA
Int J Cardiol; 2017 Dec; 248():376-381. PubMed ID: 28942878
[TBL] [Abstract][Full Text] [Related]
15. Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women.
van Kruijsdijk RC; Visseren FL; Ridker PM; Dorresteijn JA; Buring JE; van der Graaf Y; Cook NR
Heart; 2015 Mar; 101(5):369-76. PubMed ID: 25475110
[TBL] [Abstract][Full Text] [Related]
16. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.
Chan AT; Giovannucci EL; Meyerhardt JA; Schernhammer ES; Curhan GC; Fuchs CS
JAMA; 2005 Aug; 294(8):914-23. PubMed ID: 16118381
[TBL] [Abstract][Full Text] [Related]
17. Low-dose aspirin and incidence of colorectal tumors in a randomized trial.
Gann PH; Manson JE; Glynn RJ; Buring JE; Hennekens CH
J Natl Cancer Inst; 1993 Aug; 85(15):1220-4. PubMed ID: 8331682
[TBL] [Abstract][Full Text] [Related]
18. Incidence of gastrointestinal bleeding in patients with cardiovascular disease: buffered aspirin versus enteric-coated aspirin.
Hirata Y; Kataoka H; Shimura T; Mizushima T; Mizoshita T; Tanida S; Kamiya T; Joh T
Scand J Gastroenterol; 2011 Jul; 46(7-8):803-9. PubMed ID: 21501103
[TBL] [Abstract][Full Text] [Related]
19. Acute Severe Gastrointestinal Tract Bleeding Is Associated With an Increased Risk of Thromboembolism and Death.
Nagata N; Sakurai T; Shimbo T; Moriyasu S; Okubo H; Watanabe K; Yokoi C; Yanase M; Akiyama J; Uemura N
Clin Gastroenterol Hepatol; 2017 Dec; 15(12):1882-1889.e1. PubMed ID: 28634133
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
